Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2026-D-1256
Documents
1
Total comments
156
2 awaiting analysis
Comment status
Open
Last activity
Jul 2, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Feb 25, 2026Closed on Apr 28, 2026💬 156